A new cause of valvular heart disease: 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')

被引：0
|
作者：
Montastruc, F. [1 ]
Montastruc, G. [2 ]
Vigreux, P. [2 ]
Bruneval, P. [3 ]
Guilbeau-Frocher, C. [4 ]
Cron, C. [4 ]
Bagheri, H. [1 ]
Delisle, B. [4 ]
Lapeyre-Mestre, M. [1 ]
Pathak, A. [1 ]
Montastruc, J. L. [1 ]
机构：
[1] Fac Med Toulouse, INSERM, U1027, CEIP A, F-31073 Toulouse, France
[2] Clin Cedres, Toulouse, France
[3] Paris HEGP, HEGP Paris, AnatomoPathol, Toulouse, France
[4] CHU Toulouse, Toulouse, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')
    Montastruc, Francois
    Montastruc, Guillaume
    Vigreux, Philippe
    Bruneval, Patrick
    Guilbeau-Frugier, Celine
    Cron, Christophe
    Bagheri, Haleh
    Delisle, Bernadette
    Lapeyre-Mestre, Maryse
    Pathak, Atul
    Montastruc, Jean-Louis
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) : 547 - 548
  • [2] Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA)
    Morimoto, BH
    Lovell, S
    Kahr, B
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1998, 54 : 229 - 231
  • [3] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [4] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [5] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    [J]. DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [6] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    [J]. CIRCULATION, 1999, 100 (18) : 575 - 575
  • [7] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [8] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    [J]. JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [9] False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate
    Kaplan, Yusuf Cem
    Erol, Almila
    Karadas, Baris
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (05) : 493 - 495
  • [10] A review on the mitochondrial toxicity of "ecstasy" (3,4-methylenedioxymethamphetamine, MDMA)
    Capela, Joao Paulo
    Carvalho, Felix Dias
    [J]. CURRENT RESEARCH IN TOXICOLOGY, 2022, 3
12345